Molecular implications of glycosaminoglycans in diabetes pharmacotherapy.

[1]  G. Kaur,et al.  Endothelial Glycocalyx in Retina, Hyperglycemia, and Diabetic Retinopathy. , 2023, American journal of physiology. Cell physiology.

[2]  Liming Liu,et al.  Microbial synthesis of glycosaminoglycans and their oligosaccharides. , 2022, Trends in microbiology.

[3]  L. Chi,et al.  The Alterations and Roles of Glycosaminoglycans in Human Diseases , 2022, Polymers.

[4]  James A. London,et al.  Sulfated glycan recognition by carbohydrate sulfatases of the human gut microbiota , 2022, Nature Chemical Biology.

[5]  P. Seeberger,et al.  Imaging Keratan Sulfate in Ocular Tissue Sections by Immunofluorescence Microscopy and LA-ICP-MS. , 2022, ACS applied bio materials.

[6]  Jianyong Ma,et al.  Emerging Role of LncRNA Regulation for NLRP3 Inflammasome in Diabetes Complications , 2022, Frontiers in Cell and Developmental Biology.

[7]  C. Gutiérrez,et al.  The angiogenic properties of human amniotic membrane stem cells are enhanced in gestational diabetes and associate with fetal adiposity , 2021, Stem Cell Research & Therapy.

[8]  B. Duncan,et al.  IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 , 2021, Diabetes Research and Clinical Practice.

[9]  G. Miller,et al.  Developments in the Chemical Synthesis of Heparin and Heparan Sulfate , 2021, Chemical record.

[10]  R. Omelka,et al.  Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus , 2021, Pharmaceuticals.

[11]  R. Eckel,et al.  Cardiovascular disease in diabetes, beyond glucose. , 2021, Cell metabolism.

[12]  Merlin C. Thomas,et al.  Targeting the Pathobiology of Diabetic Kidney Disease , 2021, Advances in Chronic Kidney Disease.

[13]  S. Bornstein,et al.  Heparan sulfate proteoglycans in beta cells provide a critical link between endoplasmic reticulum stress, oxidative stress and type 2 diabetes , 2021, PloS one.

[14]  L. Hiebert.  Heparan Sulfate Proteoglycans in Diabetes , 2021, Seminars in Thrombosis and Hemostasis.

[15]  K. Kyriakopoulou,et al.  Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease , 2021, Seminars in Thrombosis and Hemostasis.

[16]  Anran Sheng,et al.  Glycosaminoglycan-Protein Interactions and Their Roles in Human Disease , 2021, Frontiers in Molecular Biosciences.

[17]  G. Gambaro,et al.  Sulodexide for Diabetic-Induced Disabilities: A Systematic Review and Meta-Analysis , 2021, Advances in Therapy.

[18]  Defu Li,et al.  Proteoglycans in the periodontium: A review with emphasis on specific distributions, functions, and potential applications. , 2021, Journal of periodontal research.

[19]  Tetsuhiro Tanaka,et al.  Treatment of Diabetic Kidney Disease: Current and Future , 2021, Diabetes & metabolism journal.

[20]  M. Michael Gromiha,et al.  Prediction of protein-carbohydrate complex binding affinity using structural features , 2020, Briefings Bioinform..

[21]  V. Weaver,et al.  Proteoglycans as Mediators of Cancer Tissue Mechanics , 2020, Frontiers in Cell and Developmental Biology.

[22]  L. Elling,et al.  Current state on the enzymatic synthesis of glycosaminoglycans. , 2020, Current opinion in chemical biology.

[23]  C. Nandini,et al.  AMPK differentially alters sulfated glycosaminoglycans under normal and high glucose milieu in proximal tubular cells. , 2020, Journal of biochemistry.

[24]  B. Satirapoj,et al.  Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria , 2020, Journal of diabetes research.

[25]  Sylvain D. Vallet,et al.  Glycosaminoglycan–Protein Interactions: The First Draft of the Glycosaminoglycan Interactome , 2020, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[26]  Y. Zu,et al.  Chondroitin Sulfate Prevents STZ Induced Diabetic Osteoporosis through Decreasing Blood Glucose, AntiOxidative Stress, Anti-Inflammation and OPG/RANKL Expression Regulation , 2020, International journal of molecular sciences.

[27]  Haisheng Peng,et al.  Advances in kidney-targeted drug delivery systems. , 2020, International journal of pharmaceutics.

[28]  H. Yoon,et al.  Anti-diabetic activity of field cricket glycosaminoglycan by ameliorating oxidative stress , 2020, BMC Complementary Medicine and Therapies.

[29]  Oliver C. Grant,et al.  Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions , 2020, Antiviral Research.

[30]  R. Linhardt,et al.  Analysis of the Glycosaminoglycan Chains of Proteoglycans , 2020, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[31]  R. Sanderson,et al.  Heparanase-enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression , 2020, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  P. Brun,et al.  Hyaluronic Acid: Redefining Its Role , 2020, Cells.

[33]  Daniel K. Afosah,et al.  Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies. , 2020, Current medicinal chemistry.

[34]  Nong Zhang,et al.  HGF protected against diabetic nephropathy via autophagy-lysosome pathway in podocyte by modulating PI3K/Akt-GSK3β-TFEB axis. , 2020, Cellular signalling.

[35]  A. Pessentheiner,et al.  Proteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation , 2020, Frontiers in Immunology.

[36]  T. Kyriakides,et al.  The role of extracellular matrix in the pathophysiology of diabetic wounds , 2020, Matrix biology plus.

[37]  C. Henry,et al.  Chrononutrition in the management of diabetes , 2020, Nutrition & Diabetes.

[38]  M. Mirzaei,et al.  Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health study , 2020, BMC Public Health.

[39]  Å. Lernmark,et al.  Hyaluronan deposition in islets may precede and direct the location of islet immune-cell infiltrates , 2020, Diabetologia.

[40]  B. Godeau,et al.  Matrix therapy is a cost-effective solution to reduce amputation risk and improve quality of life: pilot and case studies , 2019, Regenerative medicine research.

[41]  K. Dua,et al.  Treatment strategies against diabetes: Success so far and challenges ahead. , 2019, European journal of pharmacology.

[42]  R. Govender,et al.  Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends , 2019, Journal of epidemiology and global health.

[43]  F. Allain,et al.  The Emerging Roles of Heparan Sulfate 3-O-Sulfotransferases in Cancer , 2019, Front. Oncol..

[44]  Shravan Morla.  Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation , 2019, International journal of molecular sciences.

[45]  Joydip Kundu,et al.  Glycosaminoglycans compositional analysis of Urodele axolotl (Ambystoma mexicanum) and Porcine Retina , 2019, Glycoconjugate Journal.

[46]  Sunhwan Jo,et al.  CHARMM-GUI Glycan Modeler for modeling and simulation of carbohydrates and glycoconjugates , 2019, Glycobiology.

[47]  Chi‐Huey Wong,et al.  Oligosaccharide Synthesis and Translational Innovation. , 2019, Journal of the American Chemical Society.

[48]  M. Landers,et al.  Current management of diabetic tractional retinal detachments , 2018, Indian journal of ophthalmology.

[49]  S. Nammi,et al.  Gene therapy and type 1 diabetes mellitus. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[50]  Dalia M. Elmarakby,et al.  Histological and Immuno-Histochemical Study on the Possible Effect of Vitamin K2 on the Hepatic Oval Cells in Diabetic and Non-Diabetic Albino Rats , 2018, Egyptian Journal of Histology.

[51]  H. Argani,et al.  AGE‐RAGE axis blockade in diabetic nephropathy: Current status and future directions , 2018, European journal of pharmacology.

[52]  L. Kjellén,et al.  Specificity of glycosaminoglycan-protein interactions. , 2018, Current opinion in structural biology.

[53]  Nehru Viji Sankaranarayanan,et al.  So you think computational approaches to understanding glycosaminoglycan-protein interactions are too dry and too rigid? Think again! , 2018, Current opinion in structural biology.

[54]  J. D. de Haan,et al.  Recent novel approaches to limit oxidative stress and inflammation in diabetic complications , 2018, Clinical & translational immunology.

[55]  B. Flamion,et al.  Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[56]  J. Melrose,et al.  The multifaceted roles of perlecan in fibrosis. , 2018, Matrix biology : journal of the International Society for Matrix Biology.

[57]  J. Melrose,et al.  Keratan sulfate, a complex glycosaminoglycan with unique functional capability , 2018, Glycobiology.

[58]  I. Miller,et al.  Glycosaminoglycan-Mediated Downstream Signaling of CXCL8 Binding to Endothelial Cells , 2017, International journal of molecular sciences.

[59]  D. R. Coombe,et al.  Heparin Mimetics: Their Therapeutic Potential , 2017, Pharmaceuticals.

[60]  R. Reis,et al.  Sulfation of Glycosaminoglycans and Its Implications in Human Health and Disorders. , 2017, Annual review of biomedical engineering.

[61]  S. Canonico,et al.  To evaluate the efficacy of an acellular Flowable matrix in comparison with a wet dressing for the treatment of patients with diabetic foot ulcers: a randomized clinical trial , 2017, Updates in Surgery.

[62]  D. Papy-Garcia,et al.  RGTA® or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients , 2016, Glycoconjugate Journal.

[63]  U. Schepers,et al.  Chemical Synthesis of Glycosaminoglycans. , 2016, Chemical reviews.

[64]  D. Fernig,et al.  Heparin binding preference and structures in the fibroblast growth factor family parallel their evolutionary diversification , 2016, Open Biology.

[65]  F. Sasarman,et al.  Biosynthesis of glycosaminoglycans: associated disorders and biochemical tests , 2016, Journal of Inherited Metabolic Disease.

[66]  Vemana Gowd,et al.  Glycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulation. , 2016, World journal of diabetes.

[67]  G. Giannini,et al.  Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase , 2016, Glycobiology.

[68]  Habtamu Wondifraw Baynest.  Classification, Pathophysiology, Diagnosis and Management of Diabetes Mellitus , 2015 .

[69]  N. Wareham,et al.  Epidemiology of diabetes , 2014, Medicine.

[70]  A. Delcampe,et al.  Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers. , 2012, Investigative ophthalmology & visual science.

[71]  J. V. van Neck,et al.  Diabetes-Impaired Wound Healing Is Improved by Matrix Therapy With Heparan Sulfate Glycosaminoglycan Mimetic OTR4120 in Rats , 2012, Diabetes.

[72]  T. V. van Kuppevelt,et al.  Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice , 2011, Diabetes.

[73]  Darukeshwara Joladarashi,et al.  Diabetes results in structural alteration of chondroitin sulfate/dermatan sulfate in the rat kidney: effects on the binding to extracellular matrix components. , 2011, Glycobiology.

[74]  A. Libin,et al.  Regenerating matrix‐based therapy for chronic wound healing: a prospective within‐subject pilot study , 2011, International wound journal.

[75]  Shibo Tang,et al.  Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat. , 2009, Biochemical and biophysical research communications.

[76]  L. P. Van den Heuvel,et al.  Anti-proteinuric effects of glycosaminoglycan-based drugs. , 2007, Current opinion in molecular therapeutics.

[77]  Masayoshi Takeuchi,et al.  RAGE Control of Diabetic Nephropathy in a Mouse Model , 2006, Diabetes.

[78]  N. Wahab,et al.  J Am Soc Nephrol 14: 1358–1373, 2003 Extracellular Matrix Metabolism in Diabetic Nephropathy , 2022 .

[79]  A. Cardin,et al.  Molecular Modeling of Protein‐Glycosaminoglycan Interactions , 1989, Arteriosclerosis.

[80]  OUP accepted manuscript , 2022, Glycobiology.

[81]  C. Parish,et al.  Heparanase and Type 1 Diabetes. , 2020, Advances in experimental medicine and biology.

[82]  Silvia Rivara,et al.  The Control of Heparanase Through the Use of Small Molecules. , 2020, Advances in experimental medicine and biology.

[83]  V. Ferro,et al.  PI-88 and Related Heparan Sulfate Mimetics. , 2020, Advances in experimental medicine and biology.

[84]  S. Elli,et al.  Molecular Aspects of Heparanase Interaction with Heparan Sulfate, Heparin and Glycol Split Heparin. , 2020, Advances in experimental medicine and biology.

[85]  Link,et al.  Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability , 2011 .

[86]  G. Gambaro,et al.  Glycosaminoglycans: use in treatment of diabetic nephropathy. , 2000, Journal of the American Society of Nephrology : JASN.